<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
REGN, FB, MVRS...
11/30/2021 16:11pm
Wall Street in Fives - Must Read Lists for Tuesday

Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.

1. STOCK NEWS:

  • Fed Chair Jerome Powell suggested that QE tapering could end sooner [more]
  • Regeneron (REGN) said that it is evaluating its REGEN-COV antibody treatment against the omicron variant [more]
  • The U.K.'s Competition and Markets Authority is requiring Facebook (FB), soon to be known as Meta (MVRS), to sell Giphy [more]
  • Shopify (SHOP) said merchants' Black Friday/Cyber Monday sales rose 23% year-over-year to $6.3B [more]
  • Amazon (AMZN) said it had a "record-breaking Black Friday and Cyber Monday" [more]

2. WALL STREET CALLS:

  • Square (SQ) upgraded to Neutral from Underperform at BofA [more]
  • HSBC starts Beyond Meat (BYND) with a Reduce rating on "increasingly competitive" market [more]
  • Rocket Lab (RKLB) initiated with a Buy at BofA [more]
  • Goldman Sachs downgrades Dollar Tree (DLTR) to Neutral [more]
  • Vir Biotechnology (VIR) price target raised to $200 from $135 at H.C. Wainwright [more]

3. AROUND THE WEB:

  • Moderna (MRNA) CEO Stephane Bancel expects current COVID-19 vaccines to struggle with the omicron variant, FT reports [more]
  • Lululemon (LULU) filed a patent lawsuit against Peloton (PTON), CNBC reports [more]
  • Merck (MRK) told Reuters it believes its COVID-19 antiviral drug will have similar activity against new variants [more]
  • Biogen (BIIB) lost an appeal to revive a key patent on multiple sclerosis drug Tecfidera, Bloomberg says [more]
  • Jana Partners has a large stake in Zendesk (ZEN) and is seeking an end to the Momentive (MNTV) deal, WSJ reports [more]

4. MOVERS:

  • MEI Pharma (MEIP) surges after announcing results from the pivotal Phase 2 TIDAL study evaluating zandelisib [more]
  • ImmunityBio (IBRX) rises after entering a deal with EnGeneIC for COVID-19, cancer treatments [more]
  • RedHill Biopharma (RDHL) higher after reporting quarterly results [more]
  • Olema Oncology (OLMA) falls after releasing the first clinical data on OP-1250 [more]
  • ViacomCBS (VIAC) lower after it agreed to sell CBS Studio Center for $1.85B [more]

5. EARNINGS/GUIDANCE:

  • Citi Trends (CTRN) provided a "beat and raise" report for Q3 [more]
  • Chico's (CHS) reported upbeat Q3 earnings [more]
  • JinkoSolar (JKS) reported downbeat Q3 results [more]
  • Baozun (BZUN) reported better than expected Q3 earnings [more]
  • Barnes & Noble Education (BNED) reported lower than expected Q3 revenue [more]

INDEXES:

The Dow fell 652.22, or 1.86%, to 34,483.72, the Nasdaq lost 245.14, or 1.55%, to 15,537.69, and the S&P 500 declined 88.27, or 1.9%, to 4,567.00.

dynamic_feed Breaking News